Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Open Access
- 4 January 1996
- journal article
- review article
- Published by Elsevier in Journal of Lipid Research
- Vol. 37 (6) , 1169-1180
- https://doi.org/10.1016/s0022-2275(20)39146-x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766Gastroenterology, 1995
- Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndromeThe Journal of Pediatrics, 1995
- Smith‐Lemli‐Opitz syndrome: Prenatal diagnosis by quantification of cholesterol precursors in amniotic fluidAmerican Journal of Medical Genetics, 1995
- Prenatal diagnosis of Smith‐Lemli‐Optiz syndromeAmerican Journal of Medical Genetics, 1995
- Smith-Lemli-Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: Probable Disruption of an SLOS geneAmerican Journal of Medical Genetics, 1994
- Cholesterol metabolism in the RSH/Smith‐Lemli‐Opitz syndrome: Summary of an NICHD conferenceAmerican Journal of Medical Genetics, 1994
- Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductaseTeratology, 1983
- A syndrome characterized by mental retardation, short stature, craniofacial dysplasia, and genital anomalies occurring in siblingsThe Journal of Pediatrics, 1966
- A newly recognized syndromeof multiple congenital anomaliesThe Journal of Pediatrics, 1964
- A Novel Mode of Inhibition of Cholesterol BiosynthesisJournal of the American Chemical Society, 1963